Belite Bio, Inc (BLTE)

NASDAQ: BLTE · Real-Time Price · USD

179.12

+5.82 (3.36%)

Mar 9, 2026, 4:00 PM EDT - Market closed

Belite Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7,047	6,001	1,948	1,263	750	-
Market Cap Growth	288.30%	207.98%	54.32%	68.44%	-	-
Enterprise Value	6,771	5,726	1,861	1,221	701	-
Last Close Price	179.12	159.96	63.10	45.75	30.14	-
PB Ratio	9.15	7.79	13.36	13.96	18.06	-
P/TBV Ratio	9.15	7.79	13.37	13.96	18.06	-
Debt / Equity Ratio	-	-	0.00	0.01	0.02	-
Net Debt / Equity Ratio	-	-	-0.99	-0.96	-0.99	-1.04
Net Debt / EBITDA Ratio	-	-	3.63	2.77	3.23	1.78
Net Debt / FCF Ratio	-	-	4.93	2.92	3.48	2.30
Quick Ratio	-	-	24.09	24.50	20.01	10.61
Current Ratio	49.08	49.08	24.31	24.76	20.35	10.66
Return on Equity (ROE)	-16.94%	-16.94%	-30.60%	-47.95%	-43.45%	-46.60%
Return on Assets (ROA)	-11.29%	-11.29%	-20.26%	-28.50%	-25.59%	-27.78%
Return on Capital Employed (ROCE)	-10.90%	-10.90%	-27.40%	-34.80%	-30.40%	-58.60%
Earnings Yield	-1.10%	-1.29%	-1.85%	-2.50%	-1.69%	-
FCF Yield	-	-	-1.51%	-2.37%	-1.58%	-
Buyback Yield / Dilution	-9.82%	-9.82%	-14.83%	-33.12%	-108.74%	-8.87%

Updated Mar 2, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q